The market gained in three out of four sessions and closed the holiday-shortened week with nearly a 1% gain. On December 27, it was up by 0.3%, amid consolidation, marking a positive start for the January series. A total of 1,268 shares advanced, while 1,233 shares declined on the NSE. The market is expected to remain rangebound with a positive bias in the upcoming sessions. Below are some trading...

IPCA Laboratories Ltd has maintained robust performance in the domestic market. Given a strong product portfolio of pain management, anti-bacterial drugs, among others, as well as strong institutional business, prospects remain strong. Domestic formulations sales grew 30% year-on-year (YoY) during Q2.While domestic formulations, contributing 45% to overall sales, remained on a strong wicket, tepid...

New Delhi: Drug firm Ipca Laboratories on Saturday reported a 6.30 per cent decline in its consolidated net profit to Rs 250.23 crore for the second quarter ended September 30. The company had posted a net profit of Rs 267.07 crore for the corresponding period of the previous fiscal, Ipca Laboratories said in a regulatory filing.Consolidated revenue from operations stood at Rs 1,544.43 crore for t...

Ipca Laboratories on Wednesday informed that its board will meet next month on Saturday, 13 November, 2021, to consider the proposal for sub-division of shares of stock split of every share held into 2 shares (1:2). The board will also consider declaration of interim dividend at the meeting.The company further informed that it has decided to fix 23rd November, 2021 as the 'Record Date’ for the m...